Get ranked on Google. Get cited by ChatGPT.

Antheia Secures $80 Million Loan for Domestic Pharmaceutical Manufacturing

MENLO PARK, Calif. -- Antheia, an advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, has secured a conditional commitment for a direct, long-term loan of up to $80 million from the U.S. Department of War's Office of Strategic Capital (OSC). This funding, alongside additional private capital, will support the company’s domestic manufacturing strategy, aiming to onshore the production of critical pharmaceutical ingredients. The U.S. currently relies on foreign countries for approximately 90 percent of its supply of key starting materials (KSMs) and active pharmaceutical ingredients (APIs). This dependency leaves the nation vulnerable to drug shortages caused by public health emergencies, natural disasters, geopolitical tensions, and supply chain failures. Dr. Christina Smolke, CEO and co-founder of Antheia, emphasized the importance of securing domestic supply …

MENLO PARK, Calif. -- Antheia, an advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, has secured a conditional commitment for a direct, long-term loan of up to $80 million from the U.S. Department of War's Office of Strategic Capital (OSC). This funding, alongside additional private capital, will support the company’s domestic manufacturing strategy, aiming to onshore the production of critical pharmaceutical ingredients. The …